Andy Kuo

15PUBLICATIONS
30CO-AUTHORS
PharmacogenomicsMedical bacteriologyBiologically active moleculesComputational chemistryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 16, 2026
Preclinical Pharmacokinetics and Pharmacodynamics of Antibiotic Adjuvants.

Viet Tin Pham, David M P De Oliveira, Andy Kuo

|Apr 11, 2025
Florasulam Is a Potent Inhibitor of <i>Mycobacterium tuberculosis</i> Acetohydroxyacid Synthase and Possesses In Vivo Antituberculosis Activity.

Shun Jie Wun, Lendl Tan, Thierry G Lonhienne

|Dec 22, 2023
<i>seco</i>-1-Azacubane-2-carboxylic Acid: Derivative Scope and Comparative Biological Evaluation.

Dehui Kong, Tyler Fahrenhorst-Jones, Andy Kuo

|May 12, 2023
In Vitro Assessment of the Metabolic Stability of Two Novel Endomorphin-2 Analogs, CYX-5 and CYX-6, in Rat Liver Microsomes.

Mohammad Zafar Imam, Sussan Ghassabian, Andy Kuo

|Mar 01, 2023
Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects.

Maree T Smith, Dehui Kong, Andy Kuo

|Jan 13, 2023
CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats.

Mohammad Zafar Imam, Andy Kuo, Sussan Ghassabian

Pageof 3

Frequent Collaborators

15 joint publications

Maree T Smith

4 joint publications

Mohammad Zafar Imam

4 joint publications

Craig M Williams

3 joint publications

Sussan Ghassabian